Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel I Simon

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|January 30, 2026
Steroidal versus Non-steroidal Mineralocorticoid Receptor Antagonists in Heart failure with Preserved Ejection Fraction: A Propensity-Matched Multi-Network Nationwide Cohort StudyTalal Almas, Mohamed Shelig, Ahmed Al-Hindawi, et al.
American Journal of Preventive Cardiology|June 15, 2026
Incremental prognostic value of coronary artery calcium progression within a large community-benefit calcium score registryMichael D Glidden, Santosh K Sirasapalli, Mark Yoder, et al.
The Journal of Invasive Cardiology|March 12, 2020
Transcatheter Valve Implantation for Failed Surgical Aortic and Mitral Bioprostheses: A Single-Center ExperienceJerry Lipinski, Sandeep M Patel, Toral R Patel, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE ClearRaúl Moreno, David E Kandzari, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|October 24, 2015
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet TherapyDean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
The American Journal of Cardiology|October 5, 2015
Comparison of Outcomes of Transfemoral Transcatheter Aortic Valve Implantation Using a Minimally Invasive Versus Conventional StrategyGuilherme F Attizzani, Ahmad Alkhalil, Bimal Padaliya, et al.
JAMA|March 18, 2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trialDean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsElvin Kedhi, Stephan Windecker, Azeem Latib, et al.
Circulation. Cardiovascular Interventions|November 10, 2020
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk PatientsDavid E Kandzari, Ajay J Kirtane, Stephan Windecker, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2015
Altered Maturation Status and Possible Immune Exhaustion of CD8 T Lymphocytes in the Peripheral Blood of Patients Presenting With Acute Coronary SyndromesDavid A Zidar, Joseph C Mudd, Steven Juchnowski, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
European Heart Journal. Quality of Care & Clinical Outcomes|January 30, 2026
Steroidal versus Non-steroidal Mineralocorticoid Receptor Antagonists in Heart failure with Preserved Ejection Fraction: A Propensity-Matched Multi-Network Nationwide Cohort StudyTalal Almas, Mohamed Shelig, Ahmed Al-Hindawi, et al.
American Journal of Preventive Cardiology|June 15, 2026
Incremental prognostic value of coronary artery calcium progression within a large community-benefit calcium score registryMichael D Glidden, Santosh K Sirasapalli, Mark Yoder, et al.
The Journal of Invasive Cardiology|March 12, 2020
Transcatheter Valve Implantation for Failed Surgical Aortic and Mitral Bioprostheses: A Single-Center ExperienceJerry Lipinski, Sandeep M Patel, Toral R Patel, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE ClearRaúl Moreno, David E Kandzari, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|October 24, 2015
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet TherapyDean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
The American Journal of Cardiology|October 5, 2015
Comparison of Outcomes of Transfemoral Transcatheter Aortic Valve Implantation Using a Minimally Invasive Versus Conventional StrategyGuilherme F Attizzani, Ahmad Alkhalil, Bimal Padaliya, et al.
JAMA|March 18, 2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trialDean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsElvin Kedhi, Stephan Windecker, Azeem Latib, et al.
Circulation. Cardiovascular Interventions|November 10, 2020
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk PatientsDavid E Kandzari, Ajay J Kirtane, Stephan Windecker, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2015
Altered Maturation Status and Possible Immune Exhaustion of CD8 T Lymphocytes in the Peripheral Blood of Patients Presenting With Acute Coronary SyndromesDavid A Zidar, Joseph C Mudd, Steven Juchnowski, et al.
Pageof 16